ISSN ONLINE: 2558-815X
ISSN PRINT: 1584-9244
ISSN-L: 1584-9244

Anti-TNF Agents, Thiopurines Increase Lymphoma Risk in IBD


Many clinical trials showed that thiopurines and anti-TNF agents are very useful in treating inflammatory bowel diseases (IBD), either alone or in combination. During a study which was later published in JAMA, on November 7, it was discovered that thiopurine monotherapy, anti–tumor necrosis factor (TNF) monotherapy or a combination of both may have an increased risk for lymphoma compared with nonusers.


Comments are closed.